Michael J Rossi Net Worth

What's Michael Rossi's mailing address?

Michael's mailing address filed with the SEC is C/O Y-MABS THERAPEUTICS, INC., 230 PARK AVENUE, SUITE 3350, NEW YORK, NY, 10169.

Insiders trading at Y-Mabs Therapeutics Inc

Over the last 6 years, insiders at Y-Mabs Therapeutics Inc have traded over $85,284,951 worth of Y-Mabs Therapeutics Inc stock and bought 1,819,126 units worth $23,554,756 . The most active insiders traders include James Healy, Thomas Gad, and Johan Wedell Wedellsborg. On average, Y-Mabs Therapeutics Inc executives and independent directors trade stock every 14 days with the average trade being worth of $494,414. The most recent stock trade was executed by Torben Lund Hansen on 28 August 2024, trading 50,000 units of YMAB stock currently worth $219,000.

What does Y-Mabs Therapeutics Inc do?

y-mabs is late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. the company has a broad and advanced product pipeline, including 2 pivotal-stage product candidates - naxitamab and omburtamab - which target tumors that express gd2 and b7-h3, respectively. our mission is to become the world leader in developing antibody-based cancer products that address clear unmet needs in pediatric oncology. with the right partnerships and collaboration, we envision expanding our capabilities to treat adults - changing the course of cancer and its outcome.

Y-Mabs Therapeutics Inc executives and stock owners

Y-Mabs Therapeutics Inc executives and other stock owners filed with the SEC include:

• Dr. Claus Juan Møller San Pedro M.D., Ph.D.,
  CEO & Director
• Claus Moller-San Pedro,
  Chief Executive Officer, Director
• Thomas Gad,
  Chairman of the Board, President, Founder, Head of Business Development and Strategy
• Thomas Gad,
  Founder, Chairman, Pres and Head of Bus. Devel. & Strategy
• Bo Kruse,
  Chief Financial Officer, Executive Vice President, Treasurer, Secretary, Director
• Bo Kruse,
  Exec. VP, Sec., Treasurer & CFO
• David Gill,
  Independent Director
• James Healy,
  Independent Director
• Ashutosh Tyagi,
  Independent Director
• Gerard Ber,
  Independent Director
• Johan Wedell-Wedellsborg,
  Independent Director
• Torben Lund-Hansen,
  Senior Vice President, Chief Technical Officer
• Steen Lisby,
  Senior Vice President, Chief Medical Officer
• Philip Herman,
  Senior Vice President and Chief Commercial Officer
• Mahiuddin Ahmed,
  Senior Vice President, Chief Scientific Officer
• Joris Wilms,
  Chief Operating Officer, Senior Vice President
• Sue Smith,
  Sr. VP & Chief Commercial Officer
• Dr. Torben Lund-Hansen,
  Sr. VP & Chief Technical Officer
• Joris Wiel Jan Wilms,
  Sr. VP & COO
• Dr. Vignesh Rajah,
  Sr. VP & Chief Medical Officer
• Dr. Steen Lisby M.D., M.Sc.,
  Sr. VP & Chief Scientific Officer
• Peter P. Pfreundschuh,
  CFO and Treasurer
• Gregory S Raskin,
  Director
• Ashu Tyagi,
  Director
• Mary Tagliaferri,
  Director
• Laura Hamill,
  Director
• Vignesh Rajah,
  SVP & CHIEF MEDICAL OFFICER
• Biotech Ap S Wg,
  Director
• Susan Laura Smith,
  SVP & CHIEF COMMERCIAL OFFICER
• Michael J Rossi,
  PRESIDENT & CEO